When companies buy back their own equity, it drives up demand and can push shares higher. And 2025 is shaping up for a blockbuster year, says Rubner, who says Goldman's corporate traders estimate that ...

Goldman Sachs maintained a positive outlook on Arm Holdings (NASDAQ:ARM) shares, raising the price target to $174 from $159 ...

The anticipation surrounding dose optimization data for Pfizer (NYSE:PFE)'s obesity treatment, danuglipron, was also mentioned as a point of interest for the first quarter. However, the analyst ...